A phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
Autor: | Raj S. Pruthi, William Y. Kim, Eric Wallen, Gayle Grigson |
---|---|
Rok vydání: | 2008 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty Bladder cancer business.industry medicine.medical_treatment Urology Muscle invasive Phases of clinical research urologic and male genital diseases medicine.disease female genital diseases and pregnancy complications Cystectomy Surgical therapy Transitional cell carcinoma Internal medicine medicine In patient Erlotinib business medicine.drug |
Zdroj: | Journal of Clinical Oncology. 26:11076-11076 |
ISSN: | 1527-7755 0732-183X |
DOI: | 10.1200/jco.2008.26.15_suppl.11076 |
Popis: | 11076 Background: Despite surgical therapy, only 50% of patients undergoing radical cystectomy for transitional cell carcinoma (TCC) of the bladder will experience long-term disease-free survival. ... |
Databáze: | OpenAIRE |
Externí odkaz: |